EWA
GSK icon

Exencial Wealth Advisors’s GSK GSK Stock Holding History

Exencial Wealth Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.05M Buy
55,198
+3,736
+7% +$202K 0.09% 188
2025
Q4 		$2.52M Buy
51,462
+506
+1% +$23.6K 0.08% 200
2025
Q3 		$2.2M Buy
50,956
+3,251
+7% +$127K 0.07% 209
2025
Q2 		$1.83M Buy
47,705
+809
+2% +$30.9K 0.06% 222
2025
Q1 		$1.82M Buy
46,896
+1,028
+2% +$37.6K 0.07% 225
2024
Q4 		$1.55M Sell
45,868
-3,070
-6% -$111K 0.06% 244
2024
Q3 		$2M Buy
48,938
+321
+0.7% +$13.1K 0.07% 214
2024
Q2 		$1.87M Sell
48,617
-2,262
-4% -$95.2K 0.07% 212
2024
Q1 		$2.18M Sell
50,879
-2,109
-4% -$87K 0.08% 202
2023
Q4 		$1.96M Buy
52,988
+491
+0.9% +$17.6K 0.08% 195
2023
Q3 		$1.9M Sell
52,497
-3,589
-6% -$127K 0.09% 180
2023
Q2 		$2M Buy
56,086
+16,931
+43% +$607K 0.09% 182
2023
Q1 		$1.39M Sell
39,155
-4,191
-10% -$147K 0.07% 198
2022
Q4 		$1.52M Sell
43,346
-1,797
-4% -$59.9K 0.08% 193
2022
Q3 		$1.33M Sell
45,143
-1,719
-4% -$65.2K 0.08% 190
2022
Q2 		$2.55M Buy
46,862
+662
+1% +$36.5K 0.14% 156
2022
Q1 		$2.52M Buy
46,200
+2,422
+6% +$132K 0.13% 168
2021
Q4 		$2.41M Buy
43,778
+2,112
+5% +$110K 0.12% 176
2021
Q3 		$1.99M Buy
41,666
+1,585
+4% +$79.6K 0.09% 150
2021
Q2 		$2M Buy
40,081
+4,071
+11% +$196K 0.11% 176
2021
Q1 		$1.61M Sell
36,010
-3,160
-8% -$143K 0.1% 185
2020
Q4 		$1.8M Sell
39,170
-40,893
-51% -$1.88M 0.12% 159
2020
Q3 		$3.77M Buy
80,063
+39,281
+96% +$1.97M 0.2% 135
2020
Q2 		$2.08M Buy
+40,782
New +$2.09M 0.18% 138

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Exencial Wealth Advisors's GSK Position: Q1 2026 in Review

Exencial Wealth Advisors increased its GSK (GSK) stake by 7.3% in Q1 2026, buying an estimated $202K and bringing the position to 55,198 shares worth $3.05M. The position accounts for 0.09% of the portfolio, ranked #188.

Exencial Wealth Advisors first reported a position in GSK in Q2 2020 and has held it in 24 quarters since. The position peaked at $3.77M in Q3 2020. 1,035 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Exencial Wealth Advisors held 55,198 shares of GSK worth $3.05M as of Q1 2026.
  • Exencial Wealth Advisors bought 3,736 GSK shares in Q1 2026, an estimated $202K.
  • GSK made up 0.09% of Exencial Wealth Advisors's portfolio in Q1 2026, its #188 holding.
  • Exencial Wealth Advisors first reported a position in GSK in Q2 2020 and has held it in 24 quarters since.
  • Exencial Wealth Advisors's GSK position peaked at $3.77M in Q3 2020.
  • 1,035 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Exencial Wealth Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.